Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of [¹⁸F]MODAG-009 PET Imaging in Synucleinopathies
NCT07640555Phase 1Recruiting
- Sponsor
- MODAG
- Start
- May 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in Parkinson's disease (PD) and multiple system atrophy (MSA), sponsored by MODAG. Primary endpoint: Standard Uptake Value Ratios at 3 hours. Started May 2026; status: recruiting.
02
Conditions
Parkinson's disease (PD)multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT07640555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640555.